At a glance
ClinicalIndex Comparison RecordN/ACompleted· 86 enrolled
Drug / intervention
Diquafosol (Diquas) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial
In Brief
A clinical study evaluating Diquafosol (Diquas) and Sodium Hyaluronate (Hyalein) for Dry Eye Syndromes. Completed, enrolled 86 participants.
Detailed Summary
The purpose of this study is determine whether 3% diquafosol and 0.1% sodium hyaluronate are effective and safe in the treatment of patients with dry eye after cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartJan 2014
Primary CompletionJan 2015
First PostedNov 2015
TodayJul 2026
First PostedNov 18, 2015
Enrollment StartJan 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 10.6 years ago
Interventions
Diquafosol (Diquas)drug
Diquafosol group used diquafosol 6 times a day during study period.
Sodium Hyaluronate (Hyalein)drug
Hyaluronate group used sodium hyaluronate 6 times a day during study period.